Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
47.5M
-
Shares change
-
-1.84M
-
Total reported value, excl. options
-
$854M
-
Value change
-
-$50.7M
-
Put/Call ratio
-
1
-
Number of buys
-
80
-
Number of sells
-
-130
-
Price
-
$17.99
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q1 2020
247 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q1 2020.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.5M shares
of 56M outstanding shares and own 84.78% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.55M shares), VANGUARD GROUP INC (5.46M shares), ARMISTICE CAPITAL, LLC (3M shares), STATE STREET CORP (1.85M shares), DIMENSIONAL FUND ADVISORS LP (1.82M shares), MACQUARIE GROUP LTD (1.73M shares), MORGAN STANLEY (1.14M shares), RICE HALL JAMES & ASSOCIATES, LLC (948K shares), RENAISSANCE TECHNOLOGIES LLC (902K shares), and Invesco Ltd. (815K shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.